Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Plasma metabolites associated with coffee consumption : A metabolomic approach within the PREDIMED study. / Papandreou, Christopher; Hernández-Alonso, Pablo; Bulló, Mònica; Ruiz-Canela, Miguel; Yu, Edward; Guasch-Ferré, Marta; Toledo, Estefanía; Dennis, Courtney; Deik, Amy; Clish, Clary; Razquin, Cristina; Corella, Dolores; Estruch, Ramon; Ros, Emilio; Fitó, Montserrat; Arós, Fernando; Fiol, Miquel; Lapetra, José; Ruano, Cristina; Liang, Liming; Martínez-González, Miguel A.; Hu, Frank B.; Salas-Salvadó, Jordi.

In: Nutrients, Vol. 11, No. 5, 1032, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Papandreou, C, Hernández-Alonso, P, Bulló, M, Ruiz-Canela, M, Yu, E, Guasch-Ferré, M, Toledo, E, Dennis, C, Deik, A, Clish, C, Razquin, C, Corella, D, Estruch, R, Ros, E, Fitó, M, Arós, F, Fiol, M, Lapetra, J, Ruano, C, Liang, L, Martínez-González, MA, Hu, FB & Salas-Salvadó, J 2019, 'Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study', Nutrients, vol. 11, no. 5, 1032. https://doi.org/10.3390/nu11051032

APA

Papandreou, C., Hernández-Alonso, P., Bulló, M., Ruiz-Canela, M., Yu, E., Guasch-Ferré, M., Toledo, E., Dennis, C., Deik, A., Clish, C., Razquin, C., Corella, D., Estruch, R., Ros, E., Fitó, M., Arós, F., Fiol, M., Lapetra, J., Ruano, C., ... Salas-Salvadó, J. (2019). Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study. Nutrients, 11(5), [1032]. https://doi.org/10.3390/nu11051032

Vancouver

Papandreou C, Hernández-Alonso P, Bulló M, Ruiz-Canela M, Yu E, Guasch-Ferré M et al. Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study. Nutrients. 2019;11(5). 1032. https://doi.org/10.3390/nu11051032

Author

Papandreou, Christopher ; Hernández-Alonso, Pablo ; Bulló, Mònica ; Ruiz-Canela, Miguel ; Yu, Edward ; Guasch-Ferré, Marta ; Toledo, Estefanía ; Dennis, Courtney ; Deik, Amy ; Clish, Clary ; Razquin, Cristina ; Corella, Dolores ; Estruch, Ramon ; Ros, Emilio ; Fitó, Montserrat ; Arós, Fernando ; Fiol, Miquel ; Lapetra, José ; Ruano, Cristina ; Liang, Liming ; Martínez-González, Miguel A. ; Hu, Frank B. ; Salas-Salvadó, Jordi. / Plasma metabolites associated with coffee consumption : A metabolomic approach within the PREDIMED study. In: Nutrients. 2019 ; Vol. 11, No. 5.

Bibtex

@article{d6b97dbc74254c1fab1c59fe5536ead7,
title = "Plasma metabolites associated with coffee consumption: A metabolomic approach within the PREDIMED study",
abstract = "Few studies have examined the association of a wide range of metabolites with total and subtypes of coffee consumption. The aim of this study was to investigate associations of plasma metabolites with total, caffeinated, and decaffeinated coffee consumption. We also assessed the ability of metabolites to discriminate between coffee consumption categories. This is a cross-sectional analysis of 1664 participants from the PREDIMED study. Metabolites were semiquantitatively profiled using a multiplatform approach. Consumption of total coffee, caffeinated coffee and decaffeinated coffee was assessed by using a validated food frequency questionnaire. We assessed associations between 387 metabolite levels with total, caffeinated, or decaffeinated coffee consumption (≥50 mL coffee/day) using elastic net regression analysis. Ten-fold cross-validation analyses were used to estimate the discriminative accuracy of metabolites for total and subtypes of coffee. We identified different sets of metabolites associated with total coffee, caffeinated and decaffeinated coffee consumption. These metabolites consisted of lipid species (e.g., sphingomyelin, phosphatidylethanolamine, and phosphatidylcholine) or were derived from glycolysis (alpha-glycerophosphate) and polyphenol metabolism (hippurate). Other metabolites included caffeine, 5-acetylamino-6-amino-3-methyluracil, cotinine, kynurenic acid, glycocholate, lactate, and allantoin. The area under the curve (AUC) was 0.60 (95% CI 0.56-0.64), 0.78 (95% CI 0.75-0.81) and 0.52 (95% CI 0.49-0.55), in the multimetabolite model, for total, caffeinated, and decaffeinated coffee consumption, respectively. Our comprehensive metabolic analysis did not result in a new, reliable potential set of metabolites for coffee consumption.",
keywords = "Caffeine, Coffee, Metabolomics, Plasma, PREDIMED",
author = "Christopher Papandreou and Pablo Hern{\'a}ndez-Alonso and M{\`o}nica Bull{\'o} and Miguel Ruiz-Canela and Edward Yu and Marta Guasch-Ferr{\'e} and Estefan{\'i}a Toledo and Courtney Dennis and Amy Deik and Clary Clish and Cristina Razquin and Dolores Corella and Ramon Estruch and Emilio Ros and Montserrat Fit{\'o} and Fernando Ar{\'o}s and Miquel Fiol and Jos{\'e} Lapetra and Cristina Ruano and Liming Liang and Mart{\'i}nez-Gonz{\'a}lez, {Miguel A.} and Hu, {Frank B.} and Jordi Salas-Salvad{\'o}",
note = "Publisher Copyright: {\textcopyright} 2019 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2019",
doi = "10.3390/nu11051032",
language = "English",
volume = "11",
journal = "Nutrients",
issn = "2072-6643",
publisher = "M D P I AG",
number = "5",

}

RIS

TY - JOUR

T1 - Plasma metabolites associated with coffee consumption

T2 - A metabolomic approach within the PREDIMED study

AU - Papandreou, Christopher

AU - Hernández-Alonso, Pablo

AU - Bulló, Mònica

AU - Ruiz-Canela, Miguel

AU - Yu, Edward

AU - Guasch-Ferré, Marta

AU - Toledo, Estefanía

AU - Dennis, Courtney

AU - Deik, Amy

AU - Clish, Clary

AU - Razquin, Cristina

AU - Corella, Dolores

AU - Estruch, Ramon

AU - Ros, Emilio

AU - Fitó, Montserrat

AU - Arós, Fernando

AU - Fiol, Miquel

AU - Lapetra, José

AU - Ruano, Cristina

AU - Liang, Liming

AU - Martínez-González, Miguel A.

AU - Hu, Frank B.

AU - Salas-Salvadó, Jordi

N1 - Publisher Copyright: © 2019 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2019

Y1 - 2019

N2 - Few studies have examined the association of a wide range of metabolites with total and subtypes of coffee consumption. The aim of this study was to investigate associations of plasma metabolites with total, caffeinated, and decaffeinated coffee consumption. We also assessed the ability of metabolites to discriminate between coffee consumption categories. This is a cross-sectional analysis of 1664 participants from the PREDIMED study. Metabolites were semiquantitatively profiled using a multiplatform approach. Consumption of total coffee, caffeinated coffee and decaffeinated coffee was assessed by using a validated food frequency questionnaire. We assessed associations between 387 metabolite levels with total, caffeinated, or decaffeinated coffee consumption (≥50 mL coffee/day) using elastic net regression analysis. Ten-fold cross-validation analyses were used to estimate the discriminative accuracy of metabolites for total and subtypes of coffee. We identified different sets of metabolites associated with total coffee, caffeinated and decaffeinated coffee consumption. These metabolites consisted of lipid species (e.g., sphingomyelin, phosphatidylethanolamine, and phosphatidylcholine) or were derived from glycolysis (alpha-glycerophosphate) and polyphenol metabolism (hippurate). Other metabolites included caffeine, 5-acetylamino-6-amino-3-methyluracil, cotinine, kynurenic acid, glycocholate, lactate, and allantoin. The area under the curve (AUC) was 0.60 (95% CI 0.56-0.64), 0.78 (95% CI 0.75-0.81) and 0.52 (95% CI 0.49-0.55), in the multimetabolite model, for total, caffeinated, and decaffeinated coffee consumption, respectively. Our comprehensive metabolic analysis did not result in a new, reliable potential set of metabolites for coffee consumption.

AB - Few studies have examined the association of a wide range of metabolites with total and subtypes of coffee consumption. The aim of this study was to investigate associations of plasma metabolites with total, caffeinated, and decaffeinated coffee consumption. We also assessed the ability of metabolites to discriminate between coffee consumption categories. This is a cross-sectional analysis of 1664 participants from the PREDIMED study. Metabolites were semiquantitatively profiled using a multiplatform approach. Consumption of total coffee, caffeinated coffee and decaffeinated coffee was assessed by using a validated food frequency questionnaire. We assessed associations between 387 metabolite levels with total, caffeinated, or decaffeinated coffee consumption (≥50 mL coffee/day) using elastic net regression analysis. Ten-fold cross-validation analyses were used to estimate the discriminative accuracy of metabolites for total and subtypes of coffee. We identified different sets of metabolites associated with total coffee, caffeinated and decaffeinated coffee consumption. These metabolites consisted of lipid species (e.g., sphingomyelin, phosphatidylethanolamine, and phosphatidylcholine) or were derived from glycolysis (alpha-glycerophosphate) and polyphenol metabolism (hippurate). Other metabolites included caffeine, 5-acetylamino-6-amino-3-methyluracil, cotinine, kynurenic acid, glycocholate, lactate, and allantoin. The area under the curve (AUC) was 0.60 (95% CI 0.56-0.64), 0.78 (95% CI 0.75-0.81) and 0.52 (95% CI 0.49-0.55), in the multimetabolite model, for total, caffeinated, and decaffeinated coffee consumption, respectively. Our comprehensive metabolic analysis did not result in a new, reliable potential set of metabolites for coffee consumption.

KW - Caffeine

KW - Coffee

KW - Metabolomics

KW - Plasma

KW - PREDIMED

U2 - 10.3390/nu11051032

DO - 10.3390/nu11051032

M3 - Journal article

C2 - 31072000

AN - SCOPUS:85065886222

VL - 11

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 5

M1 - 1032

ER -

ID: 357995592